FRANKLIN RESOURCES ($BEN) posted quarterly earnings results for Q1 2026 on Friday, January 30th. The company reported earnings of $0.70 per share, beating estimates of $0.56 by $0.14. The company also reported revenue of $2,327,100,000, beating estimates of $1,730,336,373 by $596,763,627.
You can see Quiver Quantitative's $BEN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FRANKLIN RESOURCES Insider Trading Activity
FRANKLIN RESOURCES insiders have traded $BEN stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BEN stock by insiders over the last 6 months:
- CHARLES B JOHNSON has made 2 purchases buying 100,000 shares for an estimated $2,134,475 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FRANKLIN RESOURCES Hedge Fund Activity
We have seen 295 institutional investors add shares of FRANKLIN RESOURCES stock to their portfolio, and 258 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EVERGREEN QUALITY FUND GP, LTD. removed 5,237,650 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $121,146,844
- AMUNDI removed 2,867,934 shares (-85.6%) from their portfolio in Q3 2025, for an estimated $66,335,313
- CITADEL ADVISORS LLC removed 2,792,951 shares (-38.9%) from their portfolio in Q3 2025, for an estimated $64,600,956
- HOLOCENE ADVISORS, LP removed 2,099,267 shares (-97.4%) from their portfolio in Q3 2025, for an estimated $48,556,045
- PROSHARE ADVISORS LLC removed 1,838,085 shares (-21.2%) from their portfolio in Q3 2025, for an estimated $42,514,906
- ROYAL BANK OF CANADA removed 1,775,660 shares (-17.7%) from their portfolio in Q3 2025, for an estimated $41,071,015
- MORGAN STANLEY added 1,671,916 shares (+36.8%) to their portfolio in Q3 2025, for an estimated $38,671,417
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FRANKLIN RESOURCES Congressional Stock Trading
Members of Congress have traded $BEN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BEN stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 09/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FRANKLIN RESOURCES Analyst Ratings
Wall Street analysts have issued reports on $BEN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 4 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 01/15/2026
- Evercore ISI Group issued a "Underperform" rating on 10/09/2025
- BMO Capital issued a "Outperform" rating on 10/03/2025
- B of A Securities issued a "Underperform" rating on 10/02/2025
- Morgan Stanley issued a "Underweight" rating on 08/12/2025
To track analyst ratings and price targets for FRANKLIN RESOURCES, check out Quiver Quantitative's $BEN forecast page.
FRANKLIN RESOURCES Price Targets
Multiple analysts have issued price targets for $BEN recently. We have seen 7 analysts offer price targets for $BEN in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $25.0 on 01/15/2026
- Bill Katz from TD Cowen set a target price of $30.0 on 01/14/2026
- Kenneth Worthington from JP Morgan set a target price of $25.0 on 11/10/2025
- David Motemaden from Evercore ISI Group set a target price of $23.0 on 10/09/2025
- Brennan Hawken from BMO Capital set a target price of $26.0 on 10/03/2025
- Craig Siegenthaler from B of A Securities set a target price of $22.0 on 10/02/2025
- Michael Cyprys from Morgan Stanley set a target price of $21.0 on 08/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
